BWX Technologies (BWXT) director acquires additional dividend equivalent rights

Rhea-AI Filing Summary

BWX Technologies director reports small derivative award tied to deferred RSUs. A company director filed a Form 4 reporting the acquisition of 5.25 dividend equivalent rights on BWX Technologies common stock on 12/10/2025. These rights accrued on three existing restricted stock unit grants for which the director has elected to defer receipt of the underlying shares. Each restricted stock unit and each dividend equivalent right represents a contingent right to receive one share of BWX Technologies common stock. After this transaction, the director beneficially owned 41.78 dividend equivalent rights related to BWX Technologies common stock, which will be delivered proportionately over time with the associated restricted stock units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PIASECKI NICOLE WEYERHAEUSER

(Last) (First) (Middle)

800 MAIN STREET

(Street)

LYNCHBURG VA 24504

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BWX Technologies, Inc. [ BWXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	12/10/2025		A		5.25		(1)	(1)	Common Stock	5.25	$0	41.78	D

Explanation of Responses:

1. The dividend equivalent rights accrued on three restricted stock unit grants of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate.

Remarks:

	/s/ Nicole W. Piasecki, by Theresa B. Taylor, attorney-in-fact	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BWXT report in this Form 4?

The Form 4 reports a BWX Technologies director acquiring 5.25 dividend equivalent rights related to existing restricted stock unit grants on BWXT common stock as of 12/10/2025.

Who is the reporting person in this BWXT Form 4 filing?

The reporting person is a director of BWX Technologies, Inc., with the Form 4 signed on her behalf by an attorney-in-fact, Theresa B. Taylor.

What are the dividend equivalent rights disclosed for BWXT?

The dividend equivalent rights are derivatives that accrued on three restricted stock unit grants. Each restricted stock unit and each dividend equivalent right represents a contingent right to receive one share of BWXT common stock.

How many BWXT dividend equivalent rights does the director own after this transaction?

Following the reported acquisition of 5.25 dividend equivalent rights, the director beneficially owned 41.78 dividend equivalent rights related to BWXT common stock.

How and when will the BWXT dividend equivalent rights be delivered?

According to the filing, the dividend equivalent rights will be delivered to the director proportionately with the related restricted stock units, consistent with the director’s deferral election.

Does this BWXT Form 4 involve direct share purchases on the open market?

No. The reported transaction involves dividend equivalent rights tied to deferred restricted stock units, not an open-market purchase or sale of BWXT common shares.